Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis peptide

被引:118
作者
Chen, Y [1 ]
Mohanraj, VJ
Parkin, JE
机构
[1] Curtin Univ Technol, Sch Pharm, Western Australian Biomed Res Inst, Perth, WA 6845, Australia
[2] Fourrts India Labs Private Ltd, Madras, Tamil Nadu, India
来源
LETTERS IN PEPTIDE SCIENCE | 2003年 / 10卷 / 5-6期
关键词
chitosan; dextran sulphate; nanoparticles; peptide delivery; sustained-release;
D O I
10.1007/BF02442596
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel nanoparticle delivery system has been developed by employing the oppositely charged polymers chitosan (CS) and dextran sulfate (DS), and a simple coacervation process. Under the conditions investigated, the weight ratio of the two polymers is identified as a determining factor controlling particle size, surface charge, entrapment efficiency and release characteristics of the nanoparticles produced. Particles of 223 nm mean diameter were produced under optimal conditions with a zeta potential of approximately -32.6 mV. A maximum of 75% anti-angiogenesis peptide entrapment efficiency was achieved with a CS:DS weight ratio of 0.59:1. The same nanoparticle formulation also showed slow and sustained peptide release over a period of 6 days. In contrast, the formulation containing a lower ratio of CS:DS (0.5:1) was found to have reduced entrapment efficiency and more rapid peptide release characteristics. The results of this study suggest that physicochemical and release characteristics of the CS-DS nanoparticles can be modulated by changing ratios of two ionic polymers. The novel CS-DS nanoparticles. prepared by the coacervation process have potential as a carrier for small peptides.
引用
收藏
页码:621 / 629
页数:9
相关论文
共 19 条
[1]   Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis [J].
Bae, DG ;
Gho, YS ;
Yoon, WH ;
Chae, CB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (18) :13588-13596
[2]   A comparison of fluorescamine and naphthalene-2,3-dicarboxaldehyde fluorogenic reagents for microplate-based detection of amino acids [J].
Bantan-Polak, T ;
Kassai, M ;
Grant, KB .
ANALYTICAL BIOCHEMISTRY, 2001, 297 (02) :128-136
[3]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[4]  
2-4
[5]   Chitosan and chitosan ethylene oxide propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines [J].
Calvo, P ;
RemunanLopez, C ;
VilaJato, JL ;
Alonso, MJ .
PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1431-1436
[6]   SYNTHESIS OF ALBUMIN-DEXTRAN SULFATE MICROSPHERES POSSESSING FAVORABLE LOADING AND RELEASE CHARACTERISTICS FOR THE ANTICANCER DRUG DOXORUBICIN [J].
CHEN, Y ;
MCCULLOCH, RK ;
GRAY, BN .
JOURNAL OF CONTROLLED RELEASE, 1994, 31 (01) :49-54
[7]   Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice [J].
Chew, JL ;
Wolfowicz, CB ;
Mao, HQ ;
Leong, KW ;
Chua, KY .
VACCINE, 2003, 21 (21-22) :2720-2729
[8]  
FERNANDEZURRUSU.R, 1999, PHARM RES, V6, P1576
[9]  
Guerrero D.Q., 1988, DRUG DEV IND PHARM, V4, P1113
[10]   Chitosan nanoparticles as delivery systems for doxorubicin [J].
Janes, KA ;
Fresneau, MP ;
Marazuela, A ;
Fabra, A ;
Alonso, MJ .
JOURNAL OF CONTROLLED RELEASE, 2001, 73 (2-3) :255-267